Calcimedica, Common Stock Stock Today
| CALC Stock | 3.54 0.25 7.60% |
Performance0 of 100
| Odds Of DistressOver 81
|
CalciMedica, Common is trading at 3.54 as of the 2nd of January 2025, a 7.60 percent up since the beginning of the trading day. The stock's open price was 3.29. CalciMedica, Common has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 13th of January 2023 and ending today, the 2nd of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of September 2020 | Category Healthcare | Classification Health Care |
CalciMedica, Common is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 13.48 M outstanding shares of which 65.61 K shares are currently shorted by private and institutional investors with about 1.68 trading days to cover. More on CalciMedica, Common Stock
Moving together with CalciMedica, Stock
| 0.76 | APM | Aptorum Group Buyout Trend | PairCorr |
Moving against CalciMedica, Stock
CalciMedica, Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | Rachel Leheny | |||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
CalciMedica, Common can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CalciMedica, Common's financial leverage. It provides some insight into what part of CalciMedica, Common's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||
CalciMedica, Common Stock (CALC) is traded on NASDAQ Exchange in USA. It is located in 505 Coast Boulevard South, La Jolla, CA, United States, 92037 and employs 13 people. CalciMedica, Common is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 47.73 M. CalciMedica, Common Stock conducts business under Biotechnology sector and is part of Health Care industry. The entity has 13.48 M outstanding shares of which 65.61 K shares are currently shorted by private and institutional investors with about 1.68 trading days to cover.
CalciMedica, Common generates negative cash flow from operations
Check CalciMedica, Common Probability Of Bankruptcy
Ownership AllocationThe market capitalization of CalciMedica, Common Stock is USD47.73 Million. 30% of CalciMedica, Common Stock outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check CalciMedica, Ownership Details
CalciMedica, Common Historical Income Statement
CalciMedica, Stock Against Markets
CalciMedica, Common Corporate Executives
Elected by the shareholders, the CalciMedica, Common's board of directors comprises two types of representatives: CalciMedica, Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CalciMedica,. The board's role is to monitor CalciMedica, Common's management team and ensure that shareholders' interests are well served. CalciMedica, Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CalciMedica, Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kenneth Stauderman | CoFounder Officer | Profile | |
| Stefan MD | CoFounder Advisor | Profile | |
| Patrick Hogan | CoFounder Advisor | Profile | |
| Anjana Rao | CoFounder Advisor | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.